Characterization and pharmacokinetics of a novel pirarubicin liposome powder

References

• Bangham AD, Standish MM, Watkins JC. (1965). Diffusion of univalent ions across the lamellae of swollen phospholipids. J Mol Biol, 13:238–52.
   PubMed Web of Science ®Google Scholar
• Maurer N, Fenske DB, Cullis PR. (2001). Developments in liposomal drug delivery systems. Expert Opin Biol Ther, 1:923–47.
   PubMed Web of Science ®Google Scholar
• Gary T, Jain S, Singh HP, Sharma A, Tiwary AK. (2008). Elastic liposomal formulation for sustained delivery of antimigraine drug: In vitro characterization and biological evaluation. Drug Dev Ind Pharm, 34:1100–10.
   PubMed Web of Science ®Google Scholar
• Zhao L, Wei YM, Zhong XD, Liang Y, Zhang XM, Li W, . (2009). PK and tissue distribution of docetaxel in rabbits after i.v. administration of liposomal and injectable formulations. J Pharm Biomed Anal, 49:989–96.
   PubMed Web of Science ®Google Scholar
• Kawano K, Takayama K, Nagai T, Maitani Y. (2003). Preparation and pharmacokinetics of pirarubicin loaded dehydration-rehydration vesicles. Int J Pharm, 252:73–9.
   PubMedGoogle Scholar
• Shi YY, Zhao HM, Wu CX. (1993). Relative binding free energy calculations of DNA to daunomycin and its 13-dihydro analogue. Int J Biol Macromol, 15:247–51.
   PubMed Web of Science ®Google Scholar
• Koh E, Ueda Y, Nakamura T, Kobayashi A, Takahashi H. (2002). Apoptosis in young rats with adriamycin-induced cardiomyopathy-comparison with pirarubicin, a new anthracycline derivative. Pediatr Res, 51:256–9.
   PubMed Web of Science ®Google Scholar
• Dhingra K, Frye D, Newman RA, Walters R, Theriault R, Fraschini G, . (1995). Phase II clinical and pharmacological study of pirarubicin in combination with 5-fluorouracil and cyclophosphamide in static breast cancer. Clin Cancer Res, 1:691–7.
   PubMed Web of Science ®Google Scholar
• Niitsu N, Yamazaki J, Nakayama M, Umeda M. (1998). Pirarubicin-induced myocardial damage in elderly patients with non-Hodgkin’s lymphoma. Nippon Ronen Igakkai Zashi, 35:358–62.
   PubMedGoogle Scholar
• Mordente A, Meucci E, Silverstrini A, Martorana GE, Giardina B. (2009). New developments in anthracycline-induced cardiotoxicity. Curr Med Chem, 16:1656–72.
   PubMed Web of Science ®Google Scholar
• Gabizon A, Isacson R, Rosengarten O, Tzemach D, Shmeeda H, Sapir R. (2008). An open-label study to evaluate dose and cycle dependence of the pharmacokinetics of pegylated liposomal doxorubicin. Cancer Chemother Pharmacol, 61:695–702.
   PubMed Web of Science ®Google Scholar
• Tardi PG, Gallagher RC, Johnstone S, Harasym N, Webb M, Bally MB, . (2007). Coencapsulation of irinotecan and floxuridine into low cholesterol-containing liposomes that coordinate drug release in vivo. Biochim Biophys Acta-Biomembr, 1768:678–87.
   PubMed Web of Science ®Google Scholar
• Dadashzadeh S, Vali AM, Rezaie M. (2008). The effect of PEG coating on in vitro cytotoxicity and in vivo disposition of topotecan loaded liposomes in rats. Int J Pharm, 353:251–9.
   PubMed Web of Science ®Google Scholar
• Rezler EM, Khan DR, Fields JL, Cudic M, Lowell DB, Fields GB. (2007). Targeted drug delivery utilizing protein-like molecular architecture. J Am Chem Soc, 129:4961–72.
   PubMed Web of Science ®Google Scholar
• Chen J, Ping QN, Guo JX, Chu XZ, Song MM. (2006). Effect of phospholipids composition on characterization of liposomes containing 9-nitrocamptothecin. Drug Dev Ind Pharm, 32:719–26.
   PubMed Web of Science ®Google Scholar
• Zagana P, Haikou M, Giannopoulou E, Ioannou PV, Antimisiaris SG. (2009). Does the lipid membrane composition of arsonoliposomes affect their anticancer activity? A cell culture study. Mol Nutr Food Res, 53:592–9.
   PubMed Web of Science ®Google Scholar
• Kaplun YF, Touitou E. (1997). Testosterone skin permeation enhancement by menthol through formation of eutectic with drug and interaction with skin lipids. J Pharm Sci, 86:1394–9.
   PubMed Web of Science ®Google Scholar
• He J, Bernd T, Zang C, Zhang B, Zhu R, Wang F, . (2007). Unexpected effect of concomitantly administered curcumin on the pharmacokinetic of talinolol in healthy Chinese volunteers. Eur J Clin Pharmacol, 63:663–8.
   PubMed Web of Science ®Google Scholar
• Qin J, Chen DW, Lu WG, Xu H, Yan CY, Hu HY, . (2008). Preparation, characterization and evaluation of liposomal ferulic acid in vitro and in vivo. Drug Dev Ind Pharm, 34:602–8.
   PubMed Web of Science ®Google Scholar
• Dayan N, Touitou E. (2000). Carriers for skin delivery of trihexyphenidyl HCl: Ethosomes vs. liposomes. Biomaterials, 21:1879–85.
   PubMed Web of Science ®Google Scholar
• Chone S, Tauchi Y, Morimoto K. (2006). Influence of particle size on the distribution of liposomes to atherosclerotic lesions in mice. Drug Dev Ind Pharm, 32:125–35.
   PubMed Web of Science ®Google Scholar
• Medigene AG. (2008). Preparation unilamellar liposomes from suspension/solution in single-pass mode using high pressure homogenization for encapsulation of hydrophobic drugs e.g. paclitaxel, comprises extruding suspension/solution through porous device. EP 1920765-A1.
   Google Scholar
• Taylor TM, Davidson PM, Bruce BD, Weiss J. (2005). Liposomal nanocapsules in food science and agriculture. Crit Rev Food Sci Nutr, 45:587–605.
   PubMed Web of Science ®Google Scholar
• Taylor TM, Gaysinsky S, Davidson PM, Bruce BD, Weiss J. (2007). Characterization of antimicrobial-bearing liposomes by ζ-potential, vesicle size and encapsulation efficiency. Food Biophys, 2:1–9.
   Web of Science ®Google Scholar
• Lo YL, Tsai JC, Kuo JH. (2004). Liposomes and disaccharides as carriers in spray-dried powder formulations of superoxide dismutase. J Control Release, 94:259–72.
   PubMed Web of Science ®Google Scholar
• Du S, Deng Y. (2006). Studies on the encapsulation of oxymatrine into liposomes by ethanol injection and pH gradient method. Drug Dev Ind Pharm, 32:791–7.
   PubMed Web of Science ®Google Scholar
• Jahn A, Vreeland WN, DeVoe DL, Locascio LE, Gaitan M. (2007). Microfludic directed formation of liposomes of controlled size. Langmuir, 23:6289–93.
   PubMed Web of Science ®Google Scholar
• Cong W, Liu Q, Liang Q,Wang Y, Luo G. (2009). Investigation on the interactions between pirarubicin and phospholipids. Biophys Chem, 143:154–60.
   PubMed Web of Science ®Google Scholar
• Tamilvanan S. (2004). Oil-in-water lipid emulsions: Implications for parenteral and ocular delivering systems. Prog Lipid Res, 43:489–533.
   PubMed Web of Science ®Google Scholar
• Pestana KC, Formariz TP, Franzini CM, Sarmento VHV, Chiavacci LA, Scarpa MV, . (2008). Oil-in-water lecithin-based microemulsions as a potential delivery system for amphotericin B. Colloids Surf B Biointerfaces, 66:253–9.
   PubMed Web of Science ®Google Scholar
• Iguchi H, Tone H, Ishikura T, Takeuchi T, Umezawa H. (1985). Pharmacokinetics and disposition of 4′-o-tetrahydropyranyladriamycin in mice by HPLC analysis. Cancer Chemother Pharmacol, 15:132–40.
   PubMed Web of Science ®Google Scholar
• Shimizu K, Qi XR, Maitani Y, Yoshii M, Kawano K, Takayama K, . (1998). Targeting of soybean-derived sterylglucoside liposomes to liver tumors in rat and mouse models. Biol Pharm Bull, 21:741–6.
   PubMed Web of Science ®Google Scholar
• Fujita H, Ogawa K, Tone H, Iguchi H, Shomura T, Murata S. (1986). Pharmacokinetics of doxorubicin, (2″R)-4′-o-tetrahydropyranyladriamycin and aclarubicin. J Antibiot, 39:1321–36.
   Google Scholar
• Li X, Ding L, Xu Y, Wang Y, Ping Q. (2009). Targeted delivery of doxorubicin using stealth liposomes modified with transferring. Int J Pharm, 373:116–23.
   PubMed Web of Science ®Google Scholar
• Le UM, Shaker DS, Sloat BR, Cui ZR. (2008). A thermo-sensitive polymeric gel containing a gadolinium (Gd) compound encapsulated into liposomes significantly extended the retention of the Gd in tumors. Drug Dev Ind Pharm, 34:413–8.
   PubMed Web of Science ®Google Scholar